Biologics Engineering: Cell Therapy R&D Summer Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 16 hours ago

Biologics Engineering: Cell Therapy R&D Summer Intern

Alexion Pharmaceuticals, Inc. is seeking undergraduate senior and Master's level students for a 12-week internship role. The intern will work in the area of Cell Therapy R&D, focusing on wet lab skills and basic molecular biology techniques.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & Benefits
badNo H1Bnote

Qualification

Wet lab skillsMolecular biology techniquesCell culture experienceT cell biology knowledgeLentivirus transductionFlow cytometryCytotoxicity assaysSoftware proficiencyTeam collaborationProblem-solvingOrganization skills

Required

Undergraduate senior and Master's level students majoring in Biology, Immunology, Biochemistry, Chemistry or a related discipline. Candidates must have an expected graduation date after August 2026
Wet lab skills, such as primary cell culture, tumor cell culture, pipetting, etc. are required
Experience with basic molecular biology, such as PCR, gel electrophoresis, cloning/assembly, bacterial transformation, plasmid prep are required
Experience with cell culture work, including but not limited to mammalian and primary cell lines and overall aseptic techniques are required
Ability to report onsite to Gaithersburg, MD 5 days per week; this position may occasionally require onsite weekend hours. This role will not provide relocation assistance
US Work Authorization is required at time of application
This role will not be providing CPT support

Preferred

Experience with lentivirus transduction, tittering, co-culture, and flow cytometry, cell counting, and luciferase-based readouts are preferred
Experience with software including but not limited to FloJo, Megalign Pro, SeqBuilder Pro, Prism are preferred
Experience with cytotoxicity assays, such as MSD and flow cytometry are preferred
Ability to collaborate and work together in a team, stay organized, and problem-solving are preferred
Experience with software such as FloJo, Prism, Microsoft are preferred

Company

Alexion Pharmaceuticals, Inc.

company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin
Company data provided by crunchbase